| Literature DB >> 6336985 |
Abstract
A monoclonal antibody designated as T29/33, which recognizes a major cell surface glycoprotein of hematopoietic cells, was tested as a possible tool to distinguish lymphoma from nonhematopoietic tumors having a similar morphologic appearance by light microscopy. Each of the 40 lymphomas studied by immunofluorescence and/or immunoperoxidase on frozen sections revealed the presence of the corresponding antigen, whereas 110 control tumors of various nonhematopoietic origins were negative. It was concluded that the T29/33 antibody may be of value in resolving the diagnostic problems presented by tumors in which the differential diagnosis is between non-Hodgkin's lymphoma and nonlymphoid tumors.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6336985 DOI: 10.1002/1097-0142(19830301)51:5<816::aid-cncr2820510512>3.0.co;2-4
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860